gvtcx

supplier

Roche Products Ltd

AL71TW combined from 3 published records

as a supplier

112 recorded awards from 18 buyers , between 10 Aug 2017 and 3 Jun 2026.

awards won
112
exclusive
13%
15 sole-winner awards
median award
£261.9m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
Transitional Drugs 7 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £16,804,001 3 Jun 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £813,863,584 31 May 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £17,727,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
Baloxavir antiviral procurement Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency £1 29 Sept 2025
Baloxavir antiviral procurement Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency £1 29 Sept 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £688,834,174 30 Jul 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £782,917,972 30 Jul 2025
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024 shared 02182135 £46,600,000 11 Mar 2024
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A shared NHS England £334,400,000 2 Jun 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared NHS England £188,004,961 31 Jul 2019
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 4 Jul 2019

every contract won by Roche Products Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Roche Products Ltd · AL7 1TW 89
Roche Products Ltd GB-COH 00100674 AL7 1TW 13
ROCHE PRODUCTS LIMITED GB-PPON PXCG-4172-CHYM AL7 1TW 10

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works